The leadership of Meditop discuss their history as the first non-privatized, private Hungarian pharmaceutical company, their ongoing strategies for growth in the country, and their evolving portfolio abroad. They also discuss the complexities of the Hungarian healthcare and pharmaceutical market and give an overview of their past challenges and current plans for expansion.
What are the origins of Meditop, and how did the two of you begin your working relationship?
There is no doubt about the Hungarian pharmaceutical industry—all we have to do is prove our quality.
